Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S, Chen X, Fang J, Chu H, Fang S, Zeng L, Ma H, Zhang T, Chen Y, Wang T, Zhang X, Shen T, Zheng Y, Xu D, Lu Z, Pan Y, Liu Y.
Xu S, et al. Among authors: zhang t, zhang x.
Front Immunol. 2023 May 18;14:1155182. doi: 10.3389/fimmu.2023.1155182. eCollection 2023.
Front Immunol. 2023.
PMID: 37275857
Free PMC article.